Biothera announced today that new data and insights for Imprime PGG, the company’s investigational cancer immunotherapy drug, will be featured in three presentations, including a late-breaking abstract, at the European Society of Medical Oncology (ESMO) 2014 Congress on September 26-30 in Madrid.
Help employers find you! Check out all the jobs and post your resume.